San Diego, CA, United States of America

Sunil Kumar K C


Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 346(Granted Patents)


Company Filing History:


Years Active: 2006-2024

Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovations by Sunil Kumar K C: Pioneering Patents in Modern Therapeutics

Introduction

Sunil Kumar K C, based in San Diego, CA, is a prominent inventor with an impressive portfolio of 23 patents. He has made significant contributions to the field of pharmaceuticals and biochemistry, focusing on innovative compounds that address various diseases and disorders. His dedication to research and development has led to advancements that could potentially transform therapeutic practices.

Latest Patents

Among his latest patents, Sunil has developed compounds such as pyrrolo[2,1-f][1,2,4]triazines, which have been revealed to treat numerous pathologies, particularly those arising from the overexpression of DYRK1A. This includes applications in treating conditions such as cancer, Down syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis.

Another notable patent is for indazole-containing macrocycles. These compounds serve therapeutic purposes in combating various diseases, particularly those linked to the activation of Wnt pathway signaling. This includes conditions like cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, and bone or cartilage diseases, among others. His inventions offer transformative methods for treating Wnt-related diseases.

Career Highlights

Sunil Kumar K C has had a remarkable career, contributing to leading organizations in the pharmaceutical industry. He has worked at Avanir Pharmaceuticals and Samumed, which are notable companies recognized for their innovations in therapeutic solutions and drug development. His professional journey has enabled him to take part in groundbreaking research that has far-reaching implications for health and medicine.

Collaborations

Throughout his career, Sunil has collaborated with esteemed colleagues, including Jagadish C Sircar and Wenbin Ying. These partnerships have facilitated the exchange of ideas and fostered creative problem-solving, which is crucial in innovation-driven environments like pharmaceuticals.

Conclusion

Sunil Kumar K C exemplifies a commitment to innovation and excellence in the field of therapy-focused inventions. With his extensive patent portfolio and collaborative spirit, he continues to contribute to significant advancements in modern medicine. As the pharmaceutical landscape evolves, his work will likely play a key role in the development of effective treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…